lenvatinib Mesylate powder Raw Materials CAS 857890-39-2

MF:C22H23ClN4O7S

MW:522.95862

EINECS:812-398-0

Specification:lenvatinib Mesylate powder

Sample:lenvatinib Mesylate powder

Brand:lenvatinib Mesylate powder

Appearance: powder

Storage: Cool Dry Place

Brand: chemical Raw Materials

Shelf Life: 2 Years

Test Method: HPLC

Uses and synthesis of lenvatinib Mesylate powder

lenvatinib Mesylate powder is the Mesylate of Lovatinib, a multi-target tyrosine kinase inhibitor developed by Eisai, Inc. lenvatinib Mesylate CAS 857890-39-2 has a novel binding mode. In addition to inhibiting tyrosine kinases associated with other pro-angiogenic and carcinogenic signaling pathways involved in tumor proliferation, lenvatinib Mesylate Raw Materials selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors

Applications/Functions of lenvatinib Mesylate powder

• lenvatinib Mesylate powder is a multi-target tyrosine kinase inhibitor that may work against a variety of cancers, so Eisai is also investigating levatinib for other cancers
• lenvatinib Mesylate CAS 857890-39-2 is superior to sorafenib, the current standard treatment for advanced hepatocellular carcinoma.

Physicochemical Property of lenvatinib Mesylate powder